The lateral flow assay market is poised for growth via increasing home-based self-testing kits, integration with smartphones for telehealth, and expansions in food safety and environmental monitoring.

The "Acro Biotech Inc - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. Acro Biotech's diverse product lineup includes COVID-19 test products, rapid tests ...

Five undergrads started a biotech company. Their first project: an at-home technology that tests ticks for Lyme disease. It ...

Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...

Expanding access to fast, accurate syphilis testing to support Australia’s public health response. iStatis Syphilis Antibody ...

TruSpine Technologies PLC - London Gatwick Airport-based medical device company - Continues to be in a pre-revenue development phase and remains loss-making at this stage. Pretax loss widens to GBP760 ...

Six rig drill campaign continues underground; Step-out results from extension drilling at Ming Mine expected in the coming weeks; Regional exploration programmes underway KEY POINTS Latest drill resul ...

Six rig drill campaign continues underground; Step-out results from extension drilling at Ming Mine expected in the coming ...

Having expanded access to quantitative hemoglobin variant testing in 40 countries, Hemex is now also setting its sights on the US and Europe.